Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,185 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Comparison of the effect on intragastric pH of a single dose of omeprazole or rabeprazole: which is suitable for on-demand therapy?
Inamori M, Togawa J, Takahashi K, Yoneda M, Fujisawa N, Iwasaki T, Ozawa Y, Kikuchi T, Muramatsu K, Chiguchi G, Matsumoto S, Kawamura H, Abe Y, Kirikoshi H, Kobayashi N, Sakaguchi T, Takamura T, Nakajima A, Ueno N, Sekihara H. Inamori M, et al. Among authors: nakajima a. J Gastroenterol Hepatol. 2003 Sep;18(9):1034-8. doi: 10.1046/j.1440-1746.2003.03126.x. J Gastroenterol Hepatol. 2003. PMID: 12911659 Clinical Trial.
Efficacy of a triple therapy with rabeprazole, amoxicillin, and faropenem as second-line treatment after failure of initial Helicobacter pylori eradication therapy.
Togawa J, Inamori M, Fujisawa N, Takahashi H, Yoneda M, Kawamura H, Abe Y, Kirikoshi H, Kobayashi N, Sakaguchi T, Takamura T, Nakajima A, Ueno N, Sekihara H. Togawa J, et al. Among authors: nakajima a. Hepatogastroenterology. 2005 Mar-Apr;52(62):645-8. Hepatogastroenterology. 2005. PMID: 15816496 Clinical Trial.
Early effects of lafutidine or rabeprazole on intragastric acidity: which drug is more suitable for on-demand use?
Inamori M, Togawa J, Iwasaki T, Ozawa Y, Kikuchi T, Muramatsu K, Chiguchi G, Matsumoto S, Kawamura H, Abe Y, Kirikoshi H, Kobayashi N, Shimamura T, Kubota K, Sakaguchi T, Saito S, Ueno N, Nakajima A. Inamori M, et al. Among authors: nakajima a. J Gastroenterol. 2005 May;40(5):453-8. doi: 10.1007/s00535-005-1569-0. J Gastroenterol. 2005. PMID: 15942709 Clinical Trial.
Type IV collagen 7s domain is an independent clinical marker of the severity of fibrosis in patients with nonalcoholic steatohepatitis before the cirrhotic stage.
Yoneda M, Mawatari H, Fujita K, Yonemitsu K, Kato S, Takahashi H, Kirikoshi H, Inamori M, Nozaki Y, Abe Y, Kubota K, Saito S, Iwasaki T, Terauchi Y, Togo S, Maeyama S, Nakajima A. Yoneda M, et al. Among authors: nakajima a. J Gastroenterol. 2007 May;42(5):375-81. doi: 10.1007/s00535-007-2014-3. Epub 2007 May 25. J Gastroenterol. 2007. PMID: 17530362
High-sensitivity C-reactive protein is an independent clinical feature of nonalcoholic steatohepatitis (NASH) and also of the severity of fibrosis in NASH.
Yoneda M, Mawatari H, Fujita K, Iida H, Yonemitsu K, Kato S, Takahashi H, Kirikoshi H, Inamori M, Nozaki Y, Abe Y, Kubota K, Saito S, Iwasaki T, Terauchi Y, Togo S, Maeyama S, Nakajima A. Yoneda M, et al. Among authors: nakajima a. J Gastroenterol. 2007 Jul;42(7):573-82. doi: 10.1007/s00535-007-2060-x. Epub 2007 Jul 25. J Gastroenterol. 2007. PMID: 17653654
2,185 results